Search Results

Abutments are placed into the dental implants to provide support for prosthetic restoration such as crowns, bridges or overdentures.

The Straumann CARES Golden Ti/TiN Abutments are indicated for single tooth replacements and multiple tooth restorations. The prosthetic restoration is cement-retained.

The previously cleared Straumann CARES Titanium Abutments are placed onto dental implants to support prosthetic reconstructions such as crowns and bridges. The abutment allows for individual customization regarding function and esthetics. The design step is typically performed by the dental laboratory to the specifications from a clinician. The abutments are produced by a Straumann Manufacturing milling center.

The patient-specific abutment is designed by a traditional waxup and subsequent scanning or by scanning of the intraoral setting and designing the element via CAD software. The design information is sent via an Internet portal to Straumann. Straumann verifies the design against the validated design parameters. These design limits include a maximum angulation of 30° and a minimum surface area as follows:

Tooth Position, Minimum surface area mm²
7,10, 24,25, 37
4,5,12,13,20,21,28,29, 47
26,11,2,27,8,9, 43
1-3, 14-16, 17-19,30-32, 56

The abutments are manufactured from solid grade 4 titanium at the Straumann milling center. The abutment is delivered to the dental laboratory for final processing before delivery to the clinician. The abutments are attached to the implant with a titanium alloy basal screw. The occlusal restoration is affixed to the titanium abutment using dental cement.

The proposed devices are a modification of the previously licensed devices. The titanium abutments that serve as the base of the CARES Golden Ti/TiN Abutments (the uncoated abutments) are identical in every respect to the reference devices. The modification consists of the addition of a titanium nitride (TiN) coating on the emergence profile and coronal aspect of the abutment. The apical portion of the abutment consisting of the implant-to-abutment interface is masked during the coating process to assure that the interface remains uncoated.

The provided text describes the Straumann® CARES® Golden Ti/TiN Abutments, a dental device, and its substantial equivalence to predicate devices. It outlines the design, materials, and performance data used to support its clearance.

However, the document is a 510(k) summary for a medical device and therefore, it does not contain information about an AI/ML powered device, a study proving the device meets specific acceptance criteria related to AI/ML performance, or details about ground truth, expert consensus, or multi-reader multi-case studies.

Therefore, I cannot fulfill the request to provide a table of acceptance criteria and reported device performance related to an AI/ML device, nor can I provide information on sample sizes for test/training sets, data provenance, expert numbers/qualifications, adjudication methods, MRMC studies, standalone performance, or ground truth establishment relevant to AI/ML.

The document focuses on demonstrating substantial equivalence based on material, design, indications for use, and a series of standard performance tests for dental abutments.

Ask a specific question about this device

The Maestro System™ may be used in the mandible or maxilla for use as an artificial root structure for single tooth replacement or as abutments for fixed bridgework and denture retention.

The Maestro System is a comprehensive system containing implants, surgical components, and prosthetic components. This 510(k) submission notification is for the purpose of obtaining authorization to offer Ti-N coated prosthetic abutments as part of The Maestro System. The abutments will continue to be machined from titanium alloy but will undergo a Ti-N coating process. BioHorizons proposes to coat all exposed surfaces of the implant abutments during the coating process; current dimensional characteristics and specifications for abutments coated with Ti-N do not change. Cleaning, packaging and sterilization operations will be the same for the Ti-N coated abutments as for the non-coated abutments. In clinical practice, the implant and abutments surgical placement and restorative procedures will not change. The purpose of Ti-N coating implant abutments is two-fold: first, the yellow color of the Ti-N coating presents an esthetically-pleasing tint when visible through tissue, compared with the gray tint of uncoated titanium; second, the yellow color provides a distinct demarcation line at the interface of the implant body and the abutment, which will provide a visual aide in determining implant depth during the placement process. The product is packaged using materials known in the industry to be appropriate for medical device packaging and will be provided sterile, validated in compliance to ANSI/AAMI/ISO 11137, Sterilization of healthcare products - Requirements for validation and routine control - Radiation Sterilization, with a minimum sterility assurance level of 10-6.

I am unable to provide a description of the acceptance criteria and the study that proves the device meets the acceptance criteria, along with the specified information points, based on the provided text.

Here's why:

The provided text is a 510(k) summary for a device modification (adding a Titanium-Nitride coating to existing dental implant abutments). This type of submission focuses on demonstrating "substantial equivalence" to a predicate device, rather than proving that a new device meets specific, pre-defined acceptance criteria through a comprehensive performance study with statistical endpoints.

Here's a breakdown of why each requested point cannot be fully addressed:

1. A table of acceptance criteria and the reported device performance: The document does not define specific quantitative "acceptance criteria" for the performance of the Ti-N coated abutments in a clinical or functional sense. It primarily discusses the characteristics of the coating itself (adhesion, thickness, elemental composition) and its biocompatibility. It does not provide performance metrics like success rates, fracture rates, or patient outcomes that would be compared against acceptance criteria.
2. Sample size used for the test set and the data provenance: There is no mention of a "test set" in the context of clinical or performance data for the Ti-N coated abutments. The non-clinical testing refers to material property tests of the coating.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: This is not applicable as there's no clinical "test set" requiring expert ground truth establishment for diagnostic or outcome assessment.
4. Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable for the same reasons as above.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: This is entirely unrelated to the device described. The device is a physical dental implant component, not an AI diagnostic tool.
6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done: Not applicable.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): Not applicable to the device type or the nature of the 510(k) submission. The "ground truth" for the material tests would be the established scientific methods for measuring adhesion, thickness, and elemental composition.
8. The sample size for the training set: Not applicable. This is not a machine learning or AI device.
9. How the ground truth for the training set was established: Not applicable.

What the document does provide regarding "studies" and "acceptance":

The document focuses on demonstrating that the modification (the Ti-N coating) does not alter the safety or effectiveness of the previously cleared predicate device. This is achieved through:

• Predicate Device Comparison: The core of a 510(k) is showing substantial equivalence to existing, legally marketed devices.
• Biocompatibility Testing: The text explicitly states, "Biocompatibility testing has been conducted on Ti-N using the International Organization for Standardization (ISO 10993-1) guidelines. This testing, and subsequent clinical applications, has demonstrated that titanium nitride is biocompatible and appropriate for human use in implant medical devices that come in contact with bone, skin, tissue, or blood." This is a crucial "study" showing the material's safety.
• Non-Clinical Material Property Testing: "Ti-N coating applied to The Maestro System abutments was assessed in a number of tests, including adhesion and coating thickness to IonBond specification MS 70-722, and elemental composition using Energy Dispersive Spectroscopy in a scanning electron microscope at the University of Alabama at Birmingham School of Dentistry." These tests confirm the physical properties of the coating meet a specified standard (IonBond MS 70-722) and its chemical composition is as expected. This represents the "acceptance criteria" for the coating itself, not the overall device performance.

In summary, this 510(k) demonstrates the modified device is substantially equivalent by confirming the new material (Ti-N) is biocompatible and has appropriate physical properties, and that these changes do not alter the intended use or fundamental technological characteristics of the existing, cleared device. It is not a clinical effectiveness study with performance acceptance criteria for the entire device.

Ask a specific question about this device